Haplotype-based case-control study of CYP4A11 gene and myocardial infarction

Hereditas

Volumn 149, Issue 3, 2012, Pages 91-98

  Fu, Zhenyan ^a,b   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Izumi, Yoichi ^a   Kasamaki, Yuji ^a   Shindo, Atsushi ^a   Ohta, Masakatsu ^a   Soma, Masayoshi ^a   Aoi, Noriko ^a   Sato, Mikano ^a   Ozawa, Yukio ^a   Ma, Yitong ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 4A11;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PROTEIN LOCALIZATION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863862398     PISSN: 00180661     EISSN: 16015223     Source Type: Journal    
DOI: 10.1111/j.1601-5223.2012.02247.x     Document Type: Article

References (35)

1. Aoi N., Nakayama T., Soma M. et al. 2010. Association of the insulin-like growth factor1 gene with myocardial infarction in Japanese subjects. - Hereditas 147: 215-224.
2. Chu Z. M., Croft K. D., Kingsbury D. A. et al. 2000. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo. - Clin. Sci. (Lond) 98: 277-282.
3. Cornelis M. C., El-Sohemy A. and Campos H. 2004. Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. - J. Med. Genet. 41: 758-762.
4. Elbekai R. H. and El-Kadi A. O. 2006. Cytochrome P450 enzymes: central players in cardiovascular health and disease. - Pharmacol. Ther. 112: 564-587.
5. Fava C., Montagnana M., Almgren P. et al. 2008. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. - Hypertension 52: 373-380.
6. Fleming I. 2001. Cytochrome P450 and vascular homeostasis. - Circ. Res. 89: 753-762.
7. Frazier L., Johnson R. L., Sparks E. 2005. Genomics and cardiovascular disease. - J. Nurs. Scholarsh. 37: 315-321.
8. Funk M., Endler G., Freitag R. et al. 2004. CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction. - Clin. Chem. 50: 2395-2398.
9. Gainer J. V., Bellamine A., Dawson E. P. et al. 2005. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. - Circulation 111: 63-69.
10. Gross G. J., Falck J. R., Gross E. R. et al. 2005. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. - Cardiovasc. Res. 68: 18-25.
11. Hengstenberg C., Holmer S.R., Mayer B. et al. 2000. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. - Hypertension 35: 704-709.
12. Hill E., Fitzpatrick F. and Murphy R. C. 1992. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. - Br. J. Pharmacol. 106: 267-274.
13. Imig J. D., Pham B. T., LeBlanc E. A. et al. 2000. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. - Hypertension 35: 307-312.
14. Laffer C. L., Gainer J. V., Waterman M. R. et al. 2008. The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. - Hypertension 51: 767-772.
15. Letonja M., Peterlin B., Bregar D. et al. 2005. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians? - Folia Biol. (Praha) 51: 76-81.
16. Mayer B., Lieb W., Götz A. et al. 2005. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. - Hypertension 46: 766-771.
17. McGiff J. C. and Quilley J. 2001. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. - Curr. Opin. Nephrol. Hypertens. 10: 231-237.
18. Morris R. W. and Kaplan N. L. 2002. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. - Genet. Epidemiol. 23: 221-233.
19. Naganuma T., Nakayama T., Sato N. et al. 2008. Association of extracellular superoxide dismutase gene with cerebral infarction in women: a haplotype-based case-control study. - Hereditas 145: 283-292.
20. Nakayama T., Soma M., Saito S. et al. 2002. Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. - Am. Heart J. 143: 797-801.
21. Nakayama T., Asai S., Sato N. et al. 2007. PDE4D gene in the STRK1 region on 5q12: susceptibility gene for ischemic stroke. - Curr. Med. Chem. 14: 3171-3178.
22. Nithipatikom K., Gross E. R., Endsley M. P. et al. 2004. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. - Circ. Res. 95: e65-71.
23. Nordlie M. A., Wold L. E. and Kloner R. A. 2005. Genetic contributors toward increased risk for ischemic heart disease. - J. Mol. Cell. Cardiol. 39: 667-679.
24. Quigley R., Baum M., Reddy K. M. et al. 2000. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. - Am. J. Physiol. Renal. Physiol. 278: 949-953.
25. Roman R. J. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. - Physiol. Rev. 82: 131-185.
26. Schwartzman M. L., Abraham N. G., Masferrer J. et al. 1985. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. - Biochem. Biophys. Res. Commun. 132: 343-351.
27. Spiecker M., Darius H., Hankeln T. et al. 2004. Risk of coro nary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. - Circulation 110: 2132-2136.
28. Sugimoto K., Akasaka H., Katsuya T. et al. 2008. A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. - Hypertension 52: 1142-1148.
29. Vazquez B., Rios A. and Escalante B. 1995. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. - Life Sci. 56: 1455-1466.
30. Wang X. L., Greco M., Sim A. S. et al. 2002. Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. - Atherosclerosis 162: 391-397.
31. Ward N. C., Tsai I. J., Barden A. et al. 2008. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. - Hypertension 51: 1393-1398.
32. Williams J. S., Hopkins P. N., Jeunemaitre X. et al. 2011. CYP4A11 T8590C polymorphism, salt-sensitive hyperten sion, and renal blood flow. - J. Hypertens. 29: 1913-1918.
33. Winkelmann B. R. and Hager J. 2000. Genetic variation in coro nary heart disease and myocardial infarction: methodological overview and clinical evidence. - Pharmacogenomics 1: 73-94.
34. Yamaguchi M., Nakayama T., Fu Z. et al. 2010. The haplotype of the CACNA1B gene associated with cerebral infarction in Japanese. - Hereditas 147: 313-319.
35. Yasar U., Bennet A. M., Eliasson E. et al. 2003. Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. - Pharmacogenetics 13: 715-720.